The European Commission said on Tuesday that it had signed a joint procurement contract for an antiviral treatment for patients with COVID-19 with Gilead Sciences Inc.
The European Union executive said it was the second contract for this therapeutic, the first having ended in April. It added in a statement that 22 EU member states and countries are participating in the joint procurement, under which they can purchase up to 2,250,000 vials.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
New Medicaid guidance says a serious illness alone will not qualify patients for exemption from…
Florida SNAP recipients with case numbers ending in specific digit ranges are set to receive…
Automating transfers to a dedicated savings account can make homeownership goals easier to reach by…
Millions of Americans may receive their June 2026 Social Security payment on June 17 if…
Texas SNAP recipients may receive June 2026 benefits between June 15 and 21, depending on…
A 1035 exchange allows eligible insurance and annuity holders to switch contracts without immediate tax…